Dae-Woon Eom
Overview
Explore the profile of Dae-Woon Eom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee D, Jung K, Lee J, Kang H, Lee J, Kim J, et al.
Eur J Pharmacol
. 2025 Jan;
989():177272.
PMID: 39809350
Obesity due to excessive body fat accumulation remains a global problem. Patients with obesity have high cortisol levels, and its dysregulation is caused by increased 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)...
2.
Nam W, Chae H, Jung Y, Kang H, Park M, Choi A, et al.
Front Immunol
. 2023 Dec;
14:1301510.
PMID: 38143745
Introduction: Predicting the response to Bacillus Calmette-Guérin (BCG) therapy in high-risk patients with non-muscle invasive bladder cancer (NMIBC) is crucial, as failure may necessitate interventions, such as radical cystectomy or...
3.
Kim S, Yu H, Kim Y, Nam K, Chae H, Nam W, et al.
Int J Surg
. 2023 Nov;
110(2):847-858.
PMID: 37916931
Introduction: Human epidermal growth factor receptor type 2 (HER2) overexpression is a prognostic factor and a therapeutic target for breast cancer; however, anti-HER2 therapies are ineffective in patients with bladder...
4.
Noh B, Choi G, Jang H, Ma C, Oh H, Kim M, et al.
Oncol Lett
. 2022 Oct;
24(4):373.
PMID: 36238847
Indoleamine 2, 3-dioxygenase 1 (IDO1) is an immunomodulatory enzyme that catalyzes the degradation of tryptophan to kynurenine and induces immune tolerance in tumor cells. The effects of IDO1 on extrahepatic...
5.
Chae H, Nam W, Kim H, Lim S, Noh B, Kim S, et al.
Front Immunol
. 2022 Jun;
13:903297.
PMID: 35677058
Bacillus Calmette-Guérin (BCG) is the gold standard adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). However, given the current global shortage of BCG, new treatments are needed. We evaluated tumor microenvironment...
6.
Noh B, Choi G, Jang H, Ma C, Oh H, Kim M, et al.
Ann Clin Lab Sci
. 2022 Apr;
52(2):323-331.
PMID: 35414511
Objective: Pancreatic ductal adenocarcinoma (PDAC) and extrahepatic bile duct carcinoma (EBDC) are distinct entities with different clinicopathological implications. Therefore, research to differentiate between the two diseases is compulsory. In this...
7.
Song I, Jeong Y, Jung Y, Park Y, Shim S, Kim S, et al.
Redox Biol
. 2021 Nov;
48:102190.
PMID: 34798428
Cancer stem cells (CSCs) initiate tumor formation and are known to be resistant to chemotherapy. A metabolic alteration in CSCs plays a critical role in stemness and survival. However, the...
8.
Noh B, Kwak J, Eom D
BMC Cancer
. 2020 Jan;
20(1):58.
PMID: 31992245
Background: Colorectal adenocarcinoma is the third most common cancer worldwide and a leading cause of cancer-related death. The recent emergence of diverse immunotherapeutic agents has made it crucial to interpret...
9.
Noh B, Hong S, Jun S, Eom D
Pathology
. 2019 Nov;
52(2):228-235.
PMID: 31685233
The diagnosis of small intestinal adenocarcinoma (SIAC) is usually determined at an advanced stage due to non-specific symptoms and the difficulty of exploring the small intestine. Therefore, the majority of...
10.
Park C, Eom D, Ahn Y, Jang H, Hwang S, Lee S
Medicine (Baltimore)
. 2019 Jul;
98(26):e16084.
PMID: 31261522
Heme oxygenase-1 (HO-1) is an important catalytic enzyme in heme degradation, which increases during stressful conditions. It plays a major role in antioxidative and antiapoptotic processes and is associated with...